Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
18.62%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 5.47Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 44.34M | 18.62% | $ 238.06M |
| 3/31/2025 | $ 31.28M | 13.44% | $ 232.71M |
| 12/31/2024 | $ 38.92M | 16.89% | $ 230.47M |
| 9/30/2024 | $ 33.77M | 13.86% | $ 243.57M |
| 6/30/2024 | $ 33.34M | 15.22% | $ 219.14M |
| 3/31/2024 | $ 35.61M | 15.71% | $ 226.63M |
| 12/31/2023 | $ 27.01M | 11.46% | $ 235.64M |
| 9/30/2023 | $ 24.24M | 10.58% | $ 229.13M |
| 6/30/2023 | $ 30.88M | 13.42% | $ 230.12M |
| 3/31/2023 | $ 13.71M | 5.83% | $ 235.07M |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) OCF % stands at 3.39%.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average OCF % has been 6.08%.
- The median OCF % for PUMA BIOTECHNOLOGY INC during this period was 9.23%
- PUMA BIOTECHNOLOGY INC reached its highest OCF % over the past 5 years at 18.62%.
- The lowest OCF % recorded by PUMA BIOTECHNOLOGY INC in the same timeframe -17.26%
PUMA BIOTECHNOLOGY INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for PUMA BIOTECHNOLOGY INC is calculated as follows: CF - Operations [ $ 7.97M ] / Revenues [ $ 235.47M ]
(=) OCF % [ 3.39% ] PBYI - Operating Cash Flow Margin, Last 5 years
-17.26%
Minimum
Jun 30, 2022
18.62%
Maximum
Jun 30, 2025
6.08%
Average
9.23%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.31% |
| median | 12.65% |
| std | 21.13% |